Results 81 to 90 of about 9,215 (113)

Effect of Ang II Receptor Inhibition on GSK-3β/CREB/BDNF Signalling in REM Sleep Deprivation-Induced Memory Impairment. [PDF]

Neurochem Res
Elma N, Sayan Özaçmak H, Turan İ.
europepmc   +1 more source

Micellar Enhanced Second Derivative Spectrofluorimetric Determination of Hydrochlorothiazide, Amlodipine, and Telmisartan in Fixed Dose Combination and Spiked Human Plasma. [PDF]

Luminescence
Yenduri S, H S, K NP.
europepmc   +1 more source

Chromatography and Spectrometry in Food Safety and Pharmaceutical Analysis. [PDF]

Molecules
Dołowy M, Jampilek J, Bober-Majnusz K.
europepmc   +1 more source

Newly Synthesized Telmisartan-Amino Acid Conjugates Exhibit Enhanced Cytotoxic Effects in Malignant Melanoma Cells. [PDF]

Molecules
Vukadinović D, Damjanović A, Vuković M, Čudina O, Grahovac J, Dobričić V.   +5 more
europepmc   +1 more source

Telmisartan vs. other antihypertensives on cardiometabolic and vascular outcomes in diabetic hypertension: A randomised trial. [PDF]

Indian J Med Res
Gomaz SB, Kaur RJ, Mohandas A, Ambwani S, Charan J, Kumar D, Shukla R, Yadav D.   +7 more
europepmc   +1 more source

Assessing Renoprotective Effects of Empagliflozin and Telmisartan Combination Therapy in Non-albuminuric Diabetic Nephropathy: A Retrospective Cohort Study. [PDF]

Cureus
Acharya A, Kotakala CMK, Kodanda Ramu B, Padala T, Aditya Reddy P, Patnaik PK, Niharika Mede B.   +6 more
europepmc   +1 more source

An unexpected therapeutic overlap: long-term control of KCNK3-associated pulmonary arterial hypertension during treatment of systemic hypertension-a case report. [PDF]

Eur Heart J Case Rep
Carli L, di Leo M, Donato F, Barozzi C, Dardi F.   +4 more
europepmc   +1 more source

Dual-Targeted Therapy in Cardiometabolic Risk: A Meta-Analysis of Telmisartan-Based Combinations for Hypertension and Dyslipidemia. [PDF]

Clin Cardiol
Asim R, Muhammad TS, Ahmed S, Khurram L, Azeem B, Doggar ME, Muhammad AN, Chikatimalla R, Kapaganti S, Chigurupati HD, Qureshi B, Sandhyavenu H, Neppala S.   +12 more
europepmc   +1 more source

Efficacy of finerenone in reducing proteinuria in diabetic kidney disease with maximum tolerable doses of dapagliflozin and telmisartan. [PDF]

World J Nephrol
Pasari AS, Gupta S, Gurjar P, Ramteke V, Malde S, Pawar T, Jeyachandran V, Kashiv P, Dubey S, Kurundwadkar M, Sejpal K, Bawankule C, Deshpande N, Balwani MR.   +13 more
europepmc   +1 more source

Drug-associated psoriasis: a pharmacovigilance study based on the FAERS database. [PDF]

Front Pharmacol
Yi S, Liu A, Huoshen W, Xia D, Ma X.
europepmc   +1 more source